Cover Image
市場調查報告書

Shin Poong Pharm.Co., Ltd.:產品平台分析

Shin Poong Pharm.Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 305689
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Shin Poong Pharm.Co., Ltd.:產品平台分析 Shin Poong Pharm.Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年05月30日 內容資訊: 英文 26 Pages
簡介

Shin Poong Pharm.Co., Ltd.ha是開發、製造醫藥品中間體(API)和完成品的製藥企業。

本報告提供Shin Poong Pharm.Co., Ltd.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Shin Poong Pharm.Co., Ltd.的基本資料

Shin Poong Pharm.Co., Ltd.概要

  • 主要資訊
  • 企業資料

Shin Poong Pharm.Co., Ltd.:R&D概要

  • 主要的治療範圍

Shin Poong Pharm.Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Shin Poong Pharm.Co., Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Shin Poong Pharm.Co., Ltd.:藥物簡介

  • SP-8203
  • ALM-201
  • docetaxel

Shin Poong Pharm.Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Shin Poong Pharm.Co., Ltd.:最近的開發平台趨勢

Shin Poong Pharm.Co., Ltd.:暫停中的計劃

Shin Poong Pharm.Co., Ltd.:總公司和子公司的所地

附錄

目錄
Product Code: GMDHC04946CDB

Global Markets Direct's, 'Shin Poong Pharm Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Shin Poong Pharm Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Shin Poong Pharm Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Shin Poong Pharm Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Shin Poong Pharm Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Shin Poong Pharm Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Shin Poong Pharm Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Shin Poong Pharm Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Shin Poong Pharm Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Shin Poong Pharm Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Shin Poong Pharm Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Shin Poong Pharm Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Shin Poong Pharm.Co., Ltd. Snapshot
    • Shin Poong Pharm.Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Shin Poong Pharm.Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Shin Poong Pharm.Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Shin Poong Pharm.Co., Ltd. - Pipeline Products Glance
    • Shin Poong Pharm.Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Shin Poong Pharm.Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Shin Poong Pharm.Co., Ltd. - Drug Profiles
    • SP-8203
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALM-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • docetaxel
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Shin Poong Pharm.Co., Ltd. - Pipeline Analysis
    • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Target
    • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Route of Administration
    • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Molecule Type
    • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Mechanism of Action
  • Shin Poong Pharm.Co., Ltd. - Recent Pipeline Updates
  • Shin Poong Pharm.Co., Ltd. - Dormant Projects
  • Shin Poong Pharm.Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Shin Poong Pharm.Co., Ltd., Key Information
  • Shin Poong Pharm.Co., Ltd., Key Facts
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Indication, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Stage of Development, 2014
  • Shin Poong Pharm.Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Shin Poong Pharm.Co., Ltd. - Partnered Products in Pipeline, 2014
  • Shin Poong Pharm.Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Shin Poong Pharm.Co., Ltd. - Phase I, 2014
  • Shin Poong Pharm.Co., Ltd. - Preclinical, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Target, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Route of Administration, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Molecule Type, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Shin Poong Pharm.Co., Ltd. - Recent Pipeline Updates, 2014
  • Shin Poong Pharm.Co., Ltd. - Dormant Developmental Projects,2014
  • Shin Poong Pharm.Co., Ltd., Other Locations
  • Shin Poong Pharm.Co., Ltd., Subsidiaries

List of Figures

  • Shin Poong Pharm.Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Stage of Development, 2014
  • Shin Poong Pharm.Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Shin Poong Pharm.Co., Ltd. - Partnered Products in Pipeline, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Top 10 Target, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Shin Poong Pharm.Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top